Trace Amine-Associated Receptor 1 (TAAR1) agonists in a chemogenetic/molecular imaging model of increased dopamine synthesis capacity (Ki)

Project Information

TACtIK

Grant agreement ID: 101026235

DOI

10.3030/101026235

Project closed

EC signature date 9 March 2021

Start date 1 September 2021

End date 31 August 2023

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 212 933,76

EU contribution

€ 212 933,76

Coordinated by

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
United Kingdom

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (2)

Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders

Author(s): Els F Halff, Grazia Rutigliano, Anna Garcia-Hidalgo, Oliver D Howes
Published in: Trends Neurosci, Issue 2023 Jan;46(1), 2023, Page(s) 60-74, ISSN 0166-2236
Publisher: Elsevier BV
DOI: 10.1016/j.tins.2022.10.010

Therapeutic potential of taar1 agonists in schizophrenia: Evidence from preclinical models and clinical studies

Author(s): Nina Dedic, Heather Dworak, Courtney Zeni, Grazia Rutigliano, and Oliver D. Howes
Published in: International Journal of Molecular Sciences, Issue Volume 22, Issue 24, December-2 2021 Article number 13185, 2021, ISSN 1661-6596
Publisher: MDPI
DOI: 10.3390/ijms222413185